Plunkett Research Online: Adaptive Biotechnologies Corporation

ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. The company’s proprietary immune medicine platform reveals and translates the massive geneti.....



Adaptive Biotechnologies Corporation
Ticker: ADPT
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 206 659-0067
Fax: 206 659-0667
Address: 1551 Eastlake Avenue East
Suite 200
Seattle, WA 98102 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

In-Vitro Diagnostic Substance Manufacturing
Immune System Assay
Cell Sequencing
Cell Monitoring
Contacts Description

Chad Robins CEO
Chad Cohen CFO
See More
Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. The company’s proprietary immune medicine platform reveals and translates the massive geneti.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2019 2018 2017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
immunoSEQ
clonoSEQ
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: